Component

Mouse BV2 nitrite release

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Shikimic acid lowered the LPS-associated nitrite readout.

    Shikimic acid → Mouse BV2 nitrite release source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary full text retrieved; relevant methods/results/figures reviewed. Selective extraction, not raw-data reanalysis or exhaustive supplemental extraction.
    experimental_contrast
    {"intervention": "Shikimic acid in the endpoint-specific assay", "comparator": "Matched assay without shikimic acid", "endpoint": "Shikimic acid lowered the LPS-associated nitrite readout.", "effect_direction": "decrease", "combination": "single", "conditions": []} Explicit extracted experimental comparison; source-derived draft.
    experimental_model
    Mouse BV2 cells; 5/10 µM SA, LPS 1 µg/mL, 24 h for inflammatory endpoints; separate viability test.
    interpretation_status
    Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
    limitations
    Assay-specific redox or viability signal; not a unique ROS identity or direct scavenging mechanism.
    plain_language
    Shikimic acid lowered the LPS-associated nitrite readout.
    primary_references
    Shikimic acid (SA) inhibits neuro-inflammation and exerts neuroprotective effects in an LPS-induced <i>in vitro</i> and <i>in vivo</i> model. | 2023 | DOI 10.3389/fphar.2023.1265571 | PMID 38026972 | https://pubmed.ncbi.nlm.nih.gov/38026972/ | https://doi.org/10.3389/fphar.2023.1265571 | https://pmc.ncbi.nlm.nih.gov/articles/PMC10652795/
    source_locator
    Reviewed reference lines 59-59; exact primary location described in quoted passage where extracted.

    Shikimic acid: detailed mechanisms of action (reviewed 5 October 2026) · lines 59–59

    Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Mouse BV2 cells; 5/10 µM SA, LPS 1 µg/mL, 24 h for inflammatory endpoints; separate viability test. · source_derived_draft · unverified_draft

    **Microglial redox responses were measured at micromolar exposure.** In mouse BV2 cells, 5 or 10 µM shikimic acid with 1 µg/mL LPS for 24 h decreased nitrite and DCFH-DA oxidation readouts; concentrations up to 10 µM did not significantly reduce the reported CCK8 viability signal. These are assays of inflammatory/redox response and metabolic viability, not measurements of a unique reactive-oxygen species or proof of direct radical scavenging. [Shikimic acid (SA) inhibits neuro-inflammation and exerts neuroprotective effects in an LPS-induced <i>in vitro</i> and <i>in vivo</i> model.](https://pubmed.ncbi.nlm.nih.gov/38026972/)
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.